Older ALL patients can have lower rates of complete remission and more treatment-related toxicities due to decreased drug tolerance (such as asparaginase), resistance to treatment agents (corticosteroids, L-asparaginase, cytarabine, daunorubicin, vincristine) and alterations in drug metabolism [46]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.